Therefore, an MGAT2 inhibitor could ameliorate unbalanced eating habits with fat palatability and reduction of high-fat food intake could contribute to the anti-obesity effects of the MGAT2 inhibitor. This evidence concerns the gene MGAT2 and obesity due to melanocortin 4 receptor deficiency.